HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Intralesional cidofovir for recurrent laryngeal papillomas: preliminary report.

Abstract
This is a preliminary report of an ongoing study to test the efficacy of intralesional injections of the antiviral drug cidofovir in adults with recurrent laryngeal papillomas in whom multiple other treatments have previously failed. This study has been designed to include 10 to 20 patients, a number sufficient to either prove or disprove the safety and efficacy of this agent. This report conveys information on the first three patients enrolled in the trial. Each patient received an overall dose of 5 to 10 ml of cidofovir, at a concentration of 4.17 mg/ml, intralesionally at 2- to 4-week intervals. The approximate volume injected into each wart was 0.2 to 0.5 ml. Biopsies of the lesion sites were obtained at the initiation and completion of therapy. No other treatment was given. Resolution of lesions was monitored by videolaryngoscopy and still photography 1 to 2 weeks after each treatment. In time, the lesions resolved in all three patients, although all three later experienced a minor recurrence. We conclude that intralesional cidofovir appears to be a promising new treatment for controlling--and perhaps at higher dosages curing--refractory laryngeal papillomas, while causing little or no injury to laryngeal structures.
AuthorsW R Wilson, R Hashemiyoon, A Hawrych
JournalEar, nose, & throat journal (Ear Nose Throat J) Vol. 79 Issue 4 Pg. 236-8, 240 (Apr 2000) ISSN: 0145-5613 [Print] United States
PMID10786384 (Publication Type: Case Reports, Clinical Trial, Clinical Trial, Phase I, Journal Article)
Chemical References
  • Antiviral Agents
  • Organophosphonates
  • Organophosphorus Compounds
  • Cytosine
  • Cidofovir
Topics
  • Adult
  • Antiviral Agents (administration & dosage, therapeutic use)
  • Cidofovir
  • Clinical Protocols
  • Cytosine (administration & dosage, analogs & derivatives, therapeutic use)
  • Humans
  • Injections, Intralesional
  • Laryngeal Neoplasms (drug therapy, virology)
  • Male
  • Middle Aged
  • Organophosphonates
  • Organophosphorus Compounds (administration & dosage, therapeutic use)
  • Papilloma (drug therapy, virology)
  • Papillomaviridae (isolation & purification)
  • Recurrence
  • Retreatment
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: